王洋;陈豪;
WANG Yang;CHEN Hao;Pulmonary and Critical Care Medicine, First People's Hospital of Chongqing Liangjiang New Area;Pulmonary and Critical Care Medicine, Dianjiang People's Hospital;

• 1:重庆两江新区第一人民医院呼吸与危重症医学科
• 2:重庆市垫江县人民医院呼吸与危重症医学科

摘要(Abstract)：

目的探讨肺栓塞患者氧疗期间脉搏血氧饱和度(pulse oxygen saturation, SpO_2)与院内全因死亡风险的关系。方法检索2014—2015年eICU数据库中美国多家医院以肺栓塞为主要诊断的病历资料。以院内全因死亡为因变量,氧疗期间中位SpO_2为自变量构建广义相加模型(generalized additive model, GAM),分析肺栓塞患者氧疗期间中位SpO_2与院内全因死亡率的关系,并绘制曲线图,以曲线最低最平坦区域为SpO_2目标区间。采用多因素Cox回归分析法验证氧疗期间SpO_2水平与肺栓塞患者院内全因死亡风险的关系。结果共入选符合纳入和排除标准的肺栓塞患者422例,其氧疗期间中位SpO_2为97%(95%,98%),院内存活336例(79.6%),全因死亡86例(20.4%)。GAM分析结果显示,氧疗期间中位SpO_2与肺栓塞患者院内全因死亡率呈"U"形关系,中位SpO_2处于96%～98%时,院内全因死亡率最低。多因素Cox回归分析结果显示,氧疗期间SpO_2水平是肺栓塞患者发生院内全因死亡的独立影响因素,以中位SpO_2处于96%～98%患者为对照,中位SpO_2<96%患者院内全因死亡的风险增加129.8%(HR=2.298,95%CI:1.268～4.163,P=0.006),中位SpO_2>98%患者院内全因死亡风险增加77.3%(HR=1.773, 95%CI:1.068～2.942,P=0.027)。结论肺栓塞患者氧疗期间SpO_2与院内全因死亡风险呈"U"形关系,氧疗期间SpO_2处于96%～98%时,院内全因死亡风险最低,可能为氧合的目标区间。
Objective To determine the association between pulse oximetry-derived oxygen saturation(SpO_2) and all-cause in-hospital mortality of patients with pulmonary embolism during oxygen therapy. Methods Clinical data of the patients with pulmonary embolism as the primary diagnosis in different American medical institutions from the eICU database during 2014 to 2015 were retrieved. Generalized additive model(GAM) was constructed and the graph was drawn to analyze the association between median SpO_2 and all-cause in-hospital mortality. The lowest and smooth area of the curve was the optimal SpO_2 range. Moreover, the mult-ivariate Cox regression model was applied to verify the association between SpO_2 level during oxygen therapy and all-cause in-hospital mortality of patients with pulmonary embolism. Results A total of 422 patients with pulmonary embolism that met the inclusion and exclusion criteria were enrolled. The median score of SpO_2 was 97%(95%, 98%) during oxygen therapy.A total of 336(79.6%) patients were discharged from the hospital and 86(20.4%) patients died. The GAM indicated a U-shaped relationship between the median score of SpO_2 and all-cause in-hospital mortality in patients with pulmonary embolism. In addition, the lowest mortality was observed when the SpO_2 range was 96%-98%. Multivariable Cox regression analysis confirmed that the SpO_2 level was independently associated with decreased mortality. Taking patients with median SpO_2 rang of 96% to 98% as controls, the risk of all-cause in-hospital mortality was increased by 129.8% in patients with median SpO_2 <96%(HR=2.298, 95% CI:1.268-4.163,P=0.006) and 77.3% in patients with median SpO_2 >98%(HR=1.773, 95% CI: 1.068-2.942, P=0.027). Conclusions The relationship between SpO_2 levels and all-cause in-hospital mortality followed a U-shaped curve in patients with pulmonary embolism. The risk of all-cause in-hospital mortality was lowest when SpO_2 was between 96% to 98% during oxygen therapy, which may be the target range of oxygenation.

关键词(KeyWords)： 脉搏血氧饱和度;肺栓塞;高氧血症;氧疗;死亡率
pulse oxygen saturation;pulmonary embolism;hyperoxemia;oxygen therapy;mortality

Abstract:

Keywords:

基金项目(Foundation): 重庆市卫生健康委医学科研项目（2022WSJK051）~~

作者(Authors): 王洋;陈豪;
WANG Yang;CHEN Hao;Pulmonary and Critical Care Medicine, First People's Hospital of Chongqing Liangjiang New Area;Pulmonary and Critical Care Medicine, Dianjiang People's Hospital;

参考文献(References)：

• [1] Jiménez D,Bikdeli B,Barrios D,et al.Epidemiology,patterns of care and mortality for patients with hemodynamically unstable acute symptomatic pulmonary embolism[J].Int J Cardiol,2018,269:327- 333.
• [2] Turetz M,Sideris AT,Friedman OA,et al.Epidemiology,pathophysiology,and natural history of pulmonary embolism[J].Semin Intervent Radiol,2018,35:92- 98.
• [3] Fernandes CJ,Luppino Assad AP,Alves- Jr JL,et al.Pulmonary Embolism and Gas Exchange[J].Respiration,2019,98:253- 262.
• [4] Larsen K,Coolen- Allou N,Masse L,et al.Detection of Pulmonary Embolism in Returning Travelers with Hypoxemic Pneumonia due to COVID- 19 in Reunion Island[J].Am J Trop Med Hyg,2020,103:844- 846.
• [5] Ray S,Qureshi SA,Stolagiewicz N,et al.An unusual case of persisting hypoxia in a patient with a thrombolysed pulmonary embolism[J].Clin Med (Lond),2020,20:593- 596.
• [6] Han CH,Guan ZB,Zhang PX,et al.Oxidative stress induced necroptosis activation is involved in the pathogenesis of hyperoxic acute lung injury[J].Biochem Biophys Res Commun,2018,495:2178- 2183.
• [7] Asfar P,Schortgen F,Boisramé- Helms J,et al.Hyperoxia and hypertonic saline in patients with septic shock (HYPERS2S):a two- by- two factorial,multicentre,randomised,clinical trial[J].Lancet Respir Med,2017,5:180- 190.
• [8] O'Halloran HM,Kwong K,Veldhoen RA,et al.Characterizing the Patients,Hospitals,and Data Quality of the eICU Collaborative Research Database[J].Crit Care Med,2020,48:1737- 1743.
• [9] Louie A,Feiner JR,Bickler PE,et al.Four Types of Pulse Oximeters Accurately Detect Hypoxia during Low Perfusion and Motion[J].Anesthesiology,2018,128(3):520- 530.
• [10] 邹琳琳，胡忠，王进，等.基于MIMIC- Ⅲ公共数据库评价六种重症评分对呼吸重症监护患者ICU死亡风险的预测价值[J].中国呼吸与危重监护杂志，2021,20:170- 176.Zou LL,Hu Z,Wang J,et al.Evaluation the predictive values of six critical illness scores for ICU mortality in respiratory intensive care based on MIMIC- Ⅲ database[J].Zhongguo Huxi Yu Weizhong Jianhu Zazhi,2021,20:170- 176.
• [11] Zimmerman JE,Kramer AA,McNair DS,et al.Acute Physiology and Chronic Health Evaluation (APACHE) IV:hospital mortality assessment for today's critically ill patients[J].Crit Care Med,2006,34:1297- 1310.
• [12] Venetz C,Jiménez D,Mean M,et al.A comparison of the original and simplified Pulmonary Embolism Severity Index[J].Thromb Haemost,2011,106:423- 428.
• [13] Zhang Z.Multiple imputation for time series data with Amelia package[J].Ann Transl Med,2016,4:56.
• [14] 张云权，朱耀辉，李存禄，等.广义相加模型在R软件中的实现[J].中国卫生统计，2015,32:1073- 1075.Zhang YQ,Zhu YH,Li CL,et al.Operation of generalized additive model in R software[J].Zhongguo Weisheng Tongji,2015,32:1073- 1075.
• [15] Tusman G,Bohm SH,Suarez- Sipmann F.Advanced Uses of Pulse Oximetry for Monitoring Mechanically Ventilated Patients[J].Anesth Analg,2017,124:62- 71.
• [16] Allardet- Servent J,Sicard G,Metz V,et al.Benefits and risks of oxygen therapy during acute medical illness:Just a matter of dose[J].Rev Med Interne,2019,40:670- 676.
• [17] Schj?rring OL,Klitgaard TL,Perner A,et al.Lower or Higher Oxygenation Targets for Acute Hypoxemic Respiratory Failure[J].N Engl J Med,2021,8,384:1301- 1311.
• [18] Barrot L,Asfar P,Mauny F,et al.Liberal or Conservative Oxygen Therapy for Acute Respiratory Distress Syndrome[J].N Engl J Med,2020,382:999- 1008.
• [19] ICU- ROX Investigators and the Australian and New Zealand Intensive Care Society Clinical Trials Group,Mackle D,Bellomo R,et al.Conservative Oxygen Therapy during Mechanical Ventilation in the ICU[J].N Engl J Med,2020,12,382:989- 998.
• [20] Girardis M,Busani S,Damiani E,et al.Effect of Conservative vs Conventional Oxygen Therapy on Mortality Among Patients in an Intensive Care Unit:The Oxygen- ICU Randomized Clinical Trial[J].JAMA,2016,316:1583- 1589.
• [21] Palmer E,Post B,Klapaukh R,et al.The Association between Supraphysiologic Arterial Oxygen Levels and Mortality in Critically Ill Patients.A Multicenter Observational Cohort Study[J].Am J Respir Crit Care Med,2019,200:1373- 1380.
• [22] Crapo JD,Hayatdavoudi G,Knapp MJ,et al.Progressive alveolar septal injury in primates exposed to 60% oxygen for 14 days[J].Am J Physiol,1994,267:L797-L806.
• [23] Altemeier WA,Sinclair SE.Hyperoxia in the intensive care unit:why more is not always better[J].Curr Opin Crit Care,2007,13:73- 78.
• [24] Six S,Jaffal K,Ledoux G,et al.Hyperoxemia as a risk factor for ventilator- associated pneumonia[J].Crit Care,2016,20:195.
• [25] Kress JP,Hall JB.ICU- acquired weakness and recovery from critical illness[J].N Engl J Med,2014,371:287- 288.
• [26] Farquhar H,Weatherall M,Wijesinghe M,et al.Systematic review of studies of the effect of hyperoxia on coronary blood flow[J].Am Heart J,2009,158:371- 377.
• [27] Ni YN,Wang YM,Liang BM,et al.The effect of hyperoxia on mortality in critically ill patients:a systematic review and meta analysis[J].BMC Pulm Med,2019,19:53.
• [28] Martin DS,Grocott MP.Oxygen therapy in critical illness:precise control of arterial oxygenation and permissive hypoxemia[J].Crit Care Med,2013,41:423- 432.
• [29] He HW,Liu DW.Permissive hypoxemia/conservative oxygenation strategy:Dr.Jekyll or Mr.Hyde?[J].J Thorac Dis,2016,8:748- 750.
• [30] Barbateskovic M,Schj?rring OL,Russo Krauss S,et al.Higher versus lower fraction of inspired oxygen or targets of arterial oxygenation for adults admitted to the intensive care unit[J].Cochrane Database Syst Rev,2019,2019:CD012631.
• [31] Choi BM,Kang BJ,Yun HY,et al.Performance of the MP570T pulse oximeter in volunteers participating in the controlled desaturation study:a comparison of seven probes[J].Anesth Pain Med (Seoul),2020,31,15:371- 377.
• [32] Ambrisko TD,Dantino SC,Keating SCJ,et al.Repea-tability and accuracy of fingertip pulse oximeters for measurement of hemoglobin oxygen saturation in arterial blood and pulse rate in anesthetized dogs breathing 100% oxygen[J].Am J Vet Res,2021,82:268- 273.
• [33] Philip KEJ,Bennett B,Fuller S,et al.Working accuracy of pulse oximetry in COVID- 19 patients stepping down from intensive care:a clinical evaluation[J].BMJ Open Respir Res,2020,7:e000778.